Red Cell Distribution Width and its Association with Maternal Mortality in HIV-Infected Pregnancy

Abstract

Red Cell Distribution Width (RDW), a measure of the variability in red blood cell size, has gained attention for its role in diagnosing and predicting outcomes in various medical conditions. In the context of HIV-infected pregnancies, RDW may serve as a significant marker for assessing maternal health and predicting complications. This review explores the association between RDW and maternal mortality in HIV-positive pregnant women, highlighting how fluctuations in RDW can indicate underlying issues such as anemia, inflammation, and the effects of antiretroviral therapy (ART). Elevated RDW levels may correlate with increased risk of adverse outcomes, making it a potentially valuable tool in managing HIV-infected pregnancies. HIV infection complicates pregnancy by increasing the risk of adverse outcomes, including preeclampsia, gestational diabetes, and anemia, all of which can contribute to maternal mortality. RDW, by reflecting red blood cell variability, offers insights into these complications and the overall impact of HIV on maternal health. ART, crucial for managing HIV, can also influence RDW levels, as some regimens may affect red blood cell production and contribute to anemia. Monitoring RDW in conjunction with ART and other clinical parameters can enhance the detection of complications and improve management strategies.